SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-038049
Filing Date
2021-06-03
Accepted
2021-06-03 20:57:45
Documents
2
Period of Report
2021-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3348
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 2414
  Complete submission text file 0001209191-21-038049.txt   7139
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130
Business Address
GAROFALO ELIZABETH A. (Reporting) CIK: 0001826361 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36687 | Film No.: 21994553